[In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?][COVID-19로 입원한 환자에서 덱사메타손은 표준 치료에 비해 28일 사망률을 줄인다?] Published on 2020-11-012022-09-11 Journal: La Revue de médecine interne [키워드] COVID-19 Dexamethasone Mortality patients hospitalized reduce [저자] L Lanthier, M Mayette, G Huard, M-É Plourde, M Cauchon [Category] 임상, PMC URL [DOI] 10.1016/j.revmed.2020.08.005 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 COVID-19, Dexamethasone, Mortality, reduce, patients hospitalized,